BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7135165)

  • 21. Primary in vitro cytotoxic response of F1 T lymphocytes against parental antigens.
    Ishikawa H; Dutton RW
    J Immunol; 1979 Feb; 122(2):529-36. PubMed ID: 310842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant H-2-like allospecificities on K36.16 thymoma. Studies by radiobinding and immunoprecipitation with anti-H-2 monoclonal antibodies.
    Festenstein H; Hui KM
    J Immunogenet; 1986; 13(2-3):113-6. PubMed ID: 3819447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NK-mediated elimination of mutant lymphocytes that have lost expression of MHC class I molecules.
    Kusunoki Y; Kyoizumi S; Honma M; Kubo Y; Ohnishi H; Hayashi T; Seyama T
    J Immunol; 2000 Oct; 165(7):3555-63. PubMed ID: 11034355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of a defect in the H-2 genes of SV40 transformed C3H fibroblasts that do not express H-2Kk.
    Rogers MJ; Gooding LR; Margulies DH; Evans GA
    J Immunol; 1983 May; 130(5):2418-22. PubMed ID: 6300246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts.
    Drizlikh G; Schmidt-Sole J; Yankelevich B
    J Exp Med; 1984 Apr; 159(4):1070-82. PubMed ID: 6142918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical analysis of a novel H-2 class I-like glycoprotein expressed in five AKR-(Gross virus) derived spontaneous T cell leukemias.
    Labeta MO; Fernandez N; Reyes A; Ferrara P; Marelli O; Le Roy E; Houlihan J; Festenstein H
    J Immunol; 1989 Aug; 143(4):1245-53. PubMed ID: 2473124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and biochemical characterization of the H-2Kk and H-2Dk antigens from the RDM-4 lymphoma.
    Cohen SB; Coligan JE; Freed JH
    Mol Immunol; 1984 Jun; 21(6):449-59. PubMed ID: 6611487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AKR/J gene(s) unlinked to H-2 determines dominant inheritance of lymphocyte hyporesponsiveness to acetylcholine receptor.
    Gorzynski TJ; Lennon VA; Nathanson RM; David CS
    J Immunol; 1985 Apr; 134(4):2079-83. PubMed ID: 3919088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. H-2 antigen variants in a cultured heterozygous mouse leukemia cell line. VII. Effect of selection with a hybridoma antibody.
    Rajan TV
    Immunogenetics; 1980; 10(5):423-31. PubMed ID: 22457916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological and immunochemical studies of H-2 allospecificities on K36, a syngeneic tumour of AKR.
    Schmidt W; Festenstein H
    J Immunogenet; 1980 Feb; 7(1):7-17. PubMed ID: 6154751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of somatic cell H-2 variants to define the structural requirements for class I antigen expression.
    Zeff RA; Gopas J; Steinhauer E; Rajan TV; Nathenson SG
    J Immunol; 1986 Aug; 137(3):897-903. PubMed ID: 3722821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alloreactive immune responses of transgenic mice expressing a foreign transplantation antigen in a soluble form.
    Arnold B; Dill O; Küblbeck G; Jatsch L; Simon MM; Tucker J; Hämmerling GJ
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2269-73. PubMed ID: 2965390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MHC-encoded class I molecule, H-2Kk, demonstrates distinct requirements of assembly factors for cell surface expression: roles of TAP, Tapasin and beta2-microglobulin.
    Prasanna SJ; Nandi D
    Mol Immunol; 2004 Aug; 41(10):1029-45. PubMed ID: 15302165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemopoietic histocompatibility (Hh-1) phenotype and the regulation of its expression.
    Kaminsky SG; Yoshida MA; Milisauskas VK; Nakamura I
    Immunogenetics; 1992; 35(2):117-25. PubMed ID: 1735558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.
    Rager-Zisman B; Aboud M; Gopas J; Har-Vardi I; Hämmerling GJ; Segal S
    Semin Cancer Biol; 1991 Oct; 2(5):329-36. PubMed ID: 1773048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immuno-selection in vivo of H-2D phenotypic variants from a metastatic clone of sarcoma cells results in cell lines of altered metastatic competence.
    Katzav S; Segal S; Feldman M
    Int J Cancer; 1984 Mar; 33(3):407-15. PubMed ID: 6698640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquisition of immunogenicity by AKR leukemic cells following DNA-mediated gene transfer is associated with the reduction of constitutive reactive superoxide radicals.
    Chia KY; Lim SP; Oei AA; Sabapathy TK; Hui KM
    Int J Cancer; 1994 Apr; 57(2):216-23. PubMed ID: 8157360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A trans-acting mechanism represses the expression of the major transplantation antigens in mouse hybrid thymoma cell lines.
    Baldacci P; Transy C; Cochet M; Penit C; Israel A; Kourilsky P
    J Exp Med; 1986 Sep; 164(3):677-94. PubMed ID: 3746199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.